Positive Results from Phase 3 OptiTROP-Lung04 Trial of Sacituzumab Tirumotecan Presented at ESMO Presidential Symposium and Simultaneously Published in NEJM
CHENGDU, China, Oct. 20, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in Berlin, Germany, results from a Phase 3...
Cyberway:The Common Choice for Digital Transformation of FMCG Fortune 500 Industries
GUANGZHOU, China, June 22, 2025 /PRNewswire/ -- Cyberway Information Technology Co., Ltd. (hereinafter referred to as "Cyberway") is a leading digital marketing empowerment expert. Since its establishment, Cyberway has focused on the digital...
![Cyberway: 'AI Middle Platform + AI Agent' Dual Driver, [CYBER AI] Wisdom Empowerment to Build Enterprise-level AI Brain](http://prnewswire.vietreader.com/thumb/190x300/2025-06/thumbs/cyberway-ai-middle-platform-ai-agent-dual-driver-cyber-ai-wisdom-empowerment-to-build-enterprise-level-ai-brain-1.jpg)
Cyberway: 'AI Middle Platform + AI Agent' Dual Driver, [CYBER AI] Wisdom Empowerment to Build Enterprise-level AI Brain
GUANGZHOU, China, June 20, 2025 /PRNewswire/ -- With the maturation of AI technology, its application in the FMCG sector holds enormous potential. Building private AI Middle Platform and AI Agents ensures data security while delivering deep,...